Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.6 HKD | -1.66% | +2.01% | -27.49% |
04-30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
04-29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
Business Summary
Number of employees: 912
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development
100.0
%
| 116 | 100.0 % | 391 | 100.0 % | +236.26% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
99.7
%
| - | - | 390 | 99.7 % | - |
China
0.3
%
| 116 | 100.0 % | 1 | 0.3 % | -99.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 50 | 22/04/18 |
Yanrong Zhang
DFI | Director of Finance/CFO | 36 | 31/08/20 |
Joy Yan
CTO | Chief Tech/Sci/R&D Officer | 44 | 31/12/21 |
Changyu Wang
BRD | Director/Board Member | 59 | 02/03/21 |
Qian Jia
PRN | Corporate Officer/Principal | 58 | 28/02/18 |
Pak Yu Tam
SEC | Corporate Secretary | - | 28/03/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheuk Kin Law
BRD | Director/Board Member | 61 | 30/06/21 |
Yang Ke
BRD | Director/Board Member | 68 | 02/04/21 |
Bo Chen
CEO | Chief Executive Officer | 50 | 22/04/18 |
Changyu Wang
BRD | Director/Board Member | 59 | 02/03/21 |
Gang Xu
BRD | Director/Board Member | 50 | 20/06/18 |
Qi Chen
BRD | Director/Board Member | 49 | 20/06/18 |
Min Chuan Wang
BRD | Director/Board Member | 46 | 02/03/21 |
Yi Lun Liu
BRD | Director/Board Member | 38 | 02/03/21 |
Xiao Fan Wang
BRD | Director/Board Member | 68 | 02/04/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 279,735,566 | 159,688,067 ( 57.09 %) | 0 | 57.09 % |
Company contact information
Keymed Biosciences, Inc.
Tianfu International Bio-Town No. 18 BioTown Middle Road
610219, Chengdu
+86 28 8861 0620
http://www.keymedbio.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.49% | 1.26B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- 2162 Stock
- Company Keymed Biosciences Inc.